Voice outcome in Tla midcord glottic carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 134, Issue 9, 2008, Pages 965-972

  Sjögren, Elisabeth V ^a,c   Van Rossum, Maya A ^c,d   Langeveld, Ton P M ^a   Voerman, Marika S ^a   Van De Kamp, Vivienne A H ^a   Friebel, Mark O W ^a   Wolterbeek, Ron ^b   De Jong, Robert J Baatenburg ^e  

^a Department of Ear Nose and Throat Head and Neck Surgery   (Netherlands)

^b Department of Statistics ^*  (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; LARYNX CARCINOMA; LARYNX DISORDER; LASER SURGERY; MALE; TREATMENT DURATION; VOICE; CANCER STAGING; COMPARATIVE STUDY; GLOTTIS; LARYNX TUMOR; LOW LEVEL LASER THERAPY; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; RADIATION EXPOSURE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; LASER THERAPY; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; VOICE DISORDERS; VOICE QUALITY;

EID: 52249111427     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.134.9.965     Document Type: Article

References (54)

1. Brouha XD, Op DC, Terhaard CH, Hordijk GJ. Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma? Clin Otolaryngol Allied Sci. 2000;25(3):215-218.
2. Canaday DJ, Regine WF, Mohiuddin M, et al. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer. Radiat Oncol Investig. 1999; 7(1):42-48.
3. Cellai E, Frata P, Magrini SM, et al. Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers, I: the case of T1N0 disease. Int J Radiat Oncol Biol Phys. 2005;63(5):1378-1386.
4. Chatani M, Matayoski Y, Masaki N, Teshima T, Inoue T. Radiation therapy for early glottic carcinoma (T1N0M0): the final results of prospective randomized study concerning radiation field [published correction appears in Strahlenther Onkol. 1996;172(9):524]. Strahlenther Onkol. 1996;172(3):169-172.
5. Dinshaw KA, Sharma V, Agarwal JP, Ghosh S, Havaldar R. Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications. Int J Radiat Oncol Biol Phys. 2000;48(3):723-735.
6. Groome PA. O'Sullivan B, Mackillop WJ, et al. Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: population-based outcomes study supporting need for intensified treatment schedules. Int J Radiat Oncol Biol Phys. 2006;64(4):1002-1012.
7. Jin J, Liao Z, Gao L, Huang X, Xu G. Analysis of prognostic factors for T1NOMO glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy of Medical Sciences. Int J Radiat Oncol Biol Phys. 2002;54(2):471-478.
8. Le QT, Fu KK, Kroll S, et al. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys. 1997; 39(1):115-126.
9. Reddy SP, Mohideen N, Marra S, Marks JE. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer. Radiother Oncol. 1998;47(2): 161-166.
10. Rudoltz MS, Benammar A, Mohiuddin M. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Phys. 1993;26(5):767-772.
11. Skladowski K, Tarnawski R, Maciejewski B, Wygoda A, Slosarek K. Clinical radiobiology of glottic T1 squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 1999;43(1):101-106.
12. Small W Jr, Mittal BB, Brand WN, et al. Results of radiation therapy in early glottic carcinoma: multivariate analysis of prognostic and radiation therapy variables. Radiology. 1992;183(3):789-794.
13. Terhaard CH, Snippe K, Ravasz LA, van der Tweel I, Hordijk GJ. Radiotherapy in T1 laryngeal cancer: prognostic factors for loco regional control and survival, uniand multivariate analysis. Int J Radiat Oncol Biol Phys. 1991;21(5):1179-1186.
14. van derVoet JC, Keus RB, Hart AA, Hilgers FJ, Bartelink H. The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys. 1998;42(2):247-255.
15. Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys. 2006;64(1):77-82.
16. Yu E, Shenouda G, Beaudet MP, Black MJ. Impact of radiation therapy fraction size on local control of early glottic carcinoma. Int J Radiat Oncol Biol Phys. 1997; 37(3):587-591.
17. Cragle SP, Brandenburg JH. Laser cordectomy or radiotherapy: cure rates, communication, and cost. Otolaryngol Head Neck Surg. 1993;108(6):648-654.
18. 2 laser chordectomy in vocal cord carcinoma [in German], Laryngorhinootologie. 1994;73(8):432-436.
19. Eckel HE. Thumfart WF. Laser surgery for the treatment of larynx carcinomas: indications, techniques, and preliminary results. Ann Otol Rhinol Laryngol. 1992; 101(2, pt 1):113-118.
20. Lindholm CE, Elner A. Transoral laser surgery of laryngeal carcinomas: state of the art in Sweden. Adv Otorhinolaryngol. 1995;49:250-253.
21. 2 laser treatment: an effective and minimally disruptive endoscopic therapy for small glottic laryngeal carcinomas [in Dutch], Ned Tijdschr Geneeskd. 1996;140(16):886-890.
22. Myers EN, Wagner RL, Johnson JT. Microlaryngoscopic surgery for T1 glottic lesions: a cost-effective option. Ann Otol Rhinol Laryngol. 1994;103(1):28-30.
23. Rudert H. Technique and results of transoral laser surgery for small vocal cord carcinomas. Adv Otorhinolaryngol. 1995;49:222-226.
24. Shapshay SM, Hybels RL, Bohigian RK. Laser excision of early vocal cord carcinoma: indications, limitations, and precautions. Ann Otol Rhinol Laryngol. 1990; 99(1):46-50.
25. Sterner W. Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol. 1993;14(2):116-121.
26. Sterner W, Ambrosch P, Rodel RM, Kron M. Impact of anterior commissure involvement on local control of early glottic carcinoma treated by laser microresection. Laryngoscope. 2004;114(8):1485-1491.
27. 2 laser surgery for early glottic cancer in patients who are candidates for radiotherapy: results of a prospective nonrandomized study. Head Neck. 2006;28(2):121-125.
28. 2 laser cordectomy for early-stage glottic carcinoma: a long-term follow-up of 156 cases. Laryngoscope. 2002;112(2):370-374.
29. 2 laser surgery in the treatment of glottic cancer [letter]. Head Neck. 2005;27(8):733.
30. Sigston E, de Mones E, Babin E, et al. Early-stage glottic cancer: oncological results and margins in laser cordectomy. Arch Otolaryngol Head Neck Surg. 2006; 132(2):147-152.
31. Cohen SM, Garrett CG, Dupont WD, Ossoff RH, Courey MS. Voice-related quality of life in T1 glottic cancer: irradiation versus endoscopic excision. Ann Otol Rhinol Laryngol. 2006;115(8):581-586.
32. Loughran S, Calder N, MacGregor FB, Carding P, MacKenzie K. Quality of life and voice following endoscopic resection or radiotherapy for early glottic cancer. Clin Otolaryngol. 2005;30(1):42-47.
33. McGuirt WF, Blalock D, Koufman JA, et al. Comparative voice results after laser resection or irradiation of T1 vocal cord carcinoma. Arch Otolaryngol Head Neck Surg. 1994;120(9):951-955.
34. Peeters AJ, van Gogh CD, Goor KM, Verdonck-de Leeuw IM, Langendiik JA, Mahieu HF. Health status and voice outcome after treatment for T1 a glottic carcinoma. Eur Arch Otorhinolaryngol. 2004;261(10):534-540.
35. Rydell R, Schalen L, Fex S, Elner A. Voice evaluation before and after laser excision vs. radiotherapy of T1A glottic carcinoma. Acta Otolaryngol. 1995;115 (4):560-565.
36. Tamura E, Kitahara S, Ogura M, Kohno N. Voice quality after laser surgery or radiotherapy for T1a glottic carcinoma. Laryngoscope. 2003;113(5):910-914.
37. Wedman J, Heimdal JH, Elstad I, Olofsson J. Voice results in patients with T1a glottic cancer treated by radiotherapy or endoscopic measures. Eur Arch Otorhinolaryngol. 2002;259(10):547-550.
38. Dejonckere PH, Bradley P, Clemente P, et al; Committee on Phoniatrics of the European Laryngological Society (ELS). A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques: guideline elaborated by the Committee on Phoniatrics of the European Laryngological Society (ELS). Eur Arch Otorhinolaryngol. 2001;258(2):77-82.
39. Richtliin Larynxcarcinoom. Rev ed. Utrecht, the Netherlands: Kwaliteitsinstituut voor de Gezondheidszorg CBO; Nieuwegein: Nederlandse Werkgroep Hoofd-Halstumoren NWHHT; Utrecht: Vereniging van Intergrale Kankercentra; 2008. http://www.cbo.nl/product/richtlijnen/folder20021023121843/ larynxcarcinoom.pdf. Accessed June 30, 2008.
40. Remade M, Eckel HE, Antonelli A, et al. Endoscopic cordectomy: a proposal for a classification by the Working Committee, European Laryngological Society. Eur Arch Otorhinolaryngol. 2000;257(4):227-231.
41. Isshiki N, Okamura H, Tanabe M. Morimoto M. Differential diagnosis of hoarseness. Folia Phoniatr (Basel). 1969;21(1):9-19.
42. Boersma P, Weenink D. Praat Manual: A System for Doing Phonetics by Computer. Amsterdam, the Netherlands: Institute of Phonetic Sciences, University of Amsterdam; 1996. Report 132.
43. Dejonckere PH. Clinical implementation of a multidimensional basic protocol for assessing functional results of voice therapy: a preliminary study. Rev Laryngol Otol Rhinol (Bord). 2000;121(5):311-333.
44. Dejonckere PH. Assessing efficacy of voice treatments: a guideline. Rev Laryngol Otol Rhinol (Bord). 2000;121(5):307-310.
45. Hirano M. Bless D. Videostroboscopic Examination of the Larynx. San Diego, CA: Singular Publishing Group Inc; 2007.
46. Hakkesteegt MM, Wieringa MH, Gerritsma EJ, Feenstra L. Reproducibility of the Dutch version of the Voice Handicap Index. Folia Phoniatr Logop. 2006;58 (2)132-138.
47. Fleiss JL, Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons Inc; 1981:218.
48. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174.
49. Buder EH. Acoustic analysis of voice quality: a tabulation of algorithms 1902-1990. In: Ball MJ, ed. Voice Quality Measurement. San Diego, CA: Singular Publishing Group Inc; 2007:119-244.
50. Deal RE, Emanuel FW. Some waveform and spectral features of vowel roughness. J Speech Hear Res. 1978;21(2):250-264.
51. Hirano M. Objective evaluation of the human voice: clinical aspects. Folia Phoniatr (Basel). 1989;41(2-3):89-144.
52. van Gogh CD, Verdonck-de Leeuw IM, Boon-Kamma BA, et al. The efficacy of voice therapy in patients after treatment for early glottic carcinoma. Cancer. 2006; 106(1):95-105.
53. Eckel HE, Thumfart W, Jungehulsing M, Sittel C, Stennert E. Transoral laser surgery for early glottic carcinoma. Eur Arch Otorhinolaryngol. 2000;257(4):221-226.
54. Peretti G, Piazza C, Bolzoni A, et al. Analysis of recurrences in 322 Tis, T1, or T2 glottic carcinomas treated by carbon dioxide laser. Ann Otol Rhinol Laryngol. 2004;113(11):853-858.